← FDA Drug Approvals (Drugs@FDA)

ZULRESSO

NDA · New Drug Application · Sponsor: SAGE THERAP · Approved 2019-03-19

Drug application

FDA Application #

NDA211371

Application type

New Drug Application

Brand name

ZULRESSO

Generic name

Brexanolone

Active ingredients

BREXANOLONE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

SAGE THERAP

First approval

2019-03-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown